Drug Giants Create Fund to Bolster Struggling Antibiotic Start-Ups

The New York Times | July 9, 2020, 7:29 a.m. | Original
New medicines are desperately needed to treat a growing number of drug-resistant infections, but many companies developing the drugs are short on cash and investments.
Your Friday Briefing The Killing of Qassim Suleimani Was Unlawful, Says U.N. Expert